Matti Sallberg

Stockholm, AB 14186, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Immunogenomic profiling reveals targets for gene therapy in pediatric brain tumors.

Immunogenomic profiling reveals targets for gene therapy in pediatric brain tumors.

Journal: Neuro-oncology advances

Published: March 05, 2026

Integrated systems vaccinology reveals distinct metabolic responses to SARS-CoV-2 infection and DNA-based vaccines in ferrets.

Integrated systems vaccinology reveals distinct metabolic responses to SARS-CoV-2 infection and DNA-based vaccines in ferrets.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 17, 2025

A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinations.

A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinations.

Journal: Molecular therapy. Advances

Published: July 05, 2025

Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation.

Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation.

Journal: Gut

Published: October 18, 2024

Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for Invasiveness of Liver Cancer Cells.

Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for Invasiveness of Liver Cancer Cells.

Journal: Gastroenterology

Published: July 10, 2023

Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease.

Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 08, 2023

Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox.

Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox.

Journal: Cell host & microbe

Published: February 28, 2023

ATMP development and pre-GMP environment in academia: a safety net for early cell and gene therapy development and manufacturing.

ATMP development and pre-GMP environment in academia: a safety net for early cell and gene therapy development and manufacturing.

Journal: Immuno-oncology technology

Published: November 17, 2022

Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model.

Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 22, 2022

Process Development for Adoptive Cell Therapy in Academia: A Pipeline for Clinical-Scale Manufacturing of Multiple TCR-T Cell Products.

Process Development for Adoptive Cell Therapy in Academia: A Pipeline for Clinical-Scale Manufacturing of Multiple TCR-T Cell Products.

Journal: Frontiers in immunology

Published: March 14, 2022

Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections.

Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections.

Journal: Gut

Published: February 18, 2022

A universal SARS-CoV DNA vaccine inducing highly cross-reactive neutralizing antibodies and T cells.

A universal SARS-CoV DNA vaccine inducing highly cross-reactive neutralizing antibodies and T cells.

Journal: EMBO molecular medicine

Published: February 04, 2022

Showing 1-12 of 54

Last Updated: 09/26/2026